Nancy Rubin concentrates her practice in the areas of mergers and acquisitions, corporate governance, and general corporate and securities matters.

Bio

Ms. Rubin has represented buyers and sellers in public and private acquisitions and divestitures, stock and asset transactions, auctions, joint ventures and other strategic alliances.

Representations include:

  • Cineworld Group plc in its acquisition of Regal Entertainment Group for $3.6 billion;
  • Mars, Incorporated in its acquisition of Preferred Brands International, a manufacturer and marketer of Asian food products through its Tasty Bite® subsidiary, which is listed on the Bombay Stock Exchange and the National Stock Exchange of India;
  • Trimaran Fund Management, LLC in the sale of its portfolio company, ChanceLight, Inc. to The Halifax Group, LLC;
  • Horizon Pharma plc in its acquisition of the U.S. rights to PENNSAID 2% from Nuvo Research Inc.;
  • Brookfield Asset Management in its sale of MAAX Bath and MAAX Spas to American Bath Group;
  • Fox Paine and Company in its sale of Paradigm, Ltd., a maker of geoscience software, to Apax Partners and JMI Equity in a $1 billion cash merger transaction;
  • NTR, plc (Ireland) in its acquisition of a controlling interest in Stirling Energy Systems, Inc., a solar power developer;
  • Airtricity Holdings Limited (Ireland) in its sale to E.ON AG (Germany) of its North American wind operations for $1.4 billion;
  • JLL Partners and Water Street Healthcare Partners in its acquisition of Vention Medical and Aviation Technical Services; and
  • Valeant Pharmaceuticals International, Inc. in multiple transactions including:
  • $344 million acquisition of public company Obagi Medical Products, Inc. (topical skin health systems);
  • $312 million (plus potential $114 million earnout) acquisition of OraPharmaceuticals (dental industry); and
  • $250 million acquisition of public company Solta Medical, Inc. (medical devices).

In the areas of general corporate and securities matters, Ms. Rubin advises clients on securities law compliance, disclosure issues and corporate governance matters.

Ms. Rubin repeatedly has been recognized for her dedication to pro bono work. She received the 2018 Cornerstone Award from the Lawyers Alliance for New York in recognition of legal services provided to nonprofits, as well as the 2017 Pro Bono Counsel Award from Skadden’s Washington, D.C. Pro Bono Department.

She has represented nonprofit organizations on a pro bono basis, including Women’s March, Inc., NYC Kids RISE, Moment Magazine, Tuesday’s Children, Solar Energy Industries Association, Inc., The Redeem Community Development Corporation, Bridges Public Charter School and The Constitution Project.

Ms. Rubin leads training programs for Skadden associates at various levels around the country; her specialties include negotiation skills and M&A deals. Ms. Rubin also is active in the firm’s women’s leadership initiatives and serves on Skadden’s WOW committee (Women of Washington).

Ms. Rubin has authored or co-authored numerous articles and client mailings including the following:

  • “SEC Adopts Proxy Disclosure Rules on Nomination Processes”
  • “SEC Proposes Rules on Nominating Committee Process and Shareholder Communications With Board”
  • “SEC Publishes Staff Report on Nominating and Electing Corporate Directors”
  • “SEC Publishes Staff Report on Proxy Process Review”
  • “SEC Adopts Final Rules Relating to Auditors”
  • “The Sarbanes-Oxley Act of 2002 — An Overview of the Act and SEC Rulemaking”
  • “SEC Proposes Rules on Auditor Independence Under the Sarbanes-Oxley Act”

Credentials

Education

  • J.D., The University of Michigan Law School, 1986 (cum laude; Note Editor, Michigan Law Review)
  • B.A., Harvard University, 1983 (magna cum laude)

Admissions

  • New York
  • District of Columbia
  • New Jersey

Experience

  • Law Clerk to the Honorable Stanley Brotman, U.S. District Court of New Jersey

Nancy G. Rubin

Counsel, Mergers and Acquisitions; Corporate Governance
nancy.rubin@skadden.com